These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 31381546

  • 1. Drugs for smoking cessation.
    Med Lett Drugs Ther; 2019 Jul 15; 61(1576):105-110. PubMed ID: 31381546
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial.
    Benowitz NL, Pipe A, West R, Hays JT, Tonstad S, McRae T, Lawrence D, St Aubin L, Anthenelli RM.
    JAMA Intern Med; 2018 May 01; 178(5):622-631. PubMed ID: 29630702
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES Trial.
    Evins AE, Benowitz NL, West R, Russ C, McRae T, Lawrence D, Krishen A, St Aubin L, Maravic MC, Anthenelli RM.
    J Clin Psychopharmacol; 2019 May 01; 39(2):108-116. PubMed ID: 30811371
    [Abstract] [Full Text] [Related]

  • 6. Pharmacovigilance Assessment of Cardiac Implications of Nicotine Replacement Therapy Among Smokers.
    Olawuyi O, Mathieson K.
    Curr Drug Saf; 2020 May 01; 15(3):173-180. PubMed ID: 32525783
    [Abstract] [Full Text] [Related]

  • 7. Discovery and development of varenicline for smoking cessation.
    Jordan CJ, Xi ZX.
    Expert Opin Drug Discov; 2018 Jul 01; 13(7):671-683. PubMed ID: 29587555
    [Abstract] [Full Text] [Related]

  • 8. Frequently Reported Adverse Events With Smoking Cessation Medications: Post Hoc Analysis of a Randomized Trial.
    Ebbert J, Jimenez-Ruiz C, Dutro MP, Fisher M, Li J, Hays JT.
    Mayo Clin Proc; 2021 Jul 01; 96(7):1801-1811. PubMed ID: 34112520
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Smoking cessation: Pharmacological strategies different from standard treatments].
    Underner M, Perriot J, Peiffer G, Harika-Germaneau G, Jaafari N.
    Rev Pneumol Clin; 2018 Sep 01; 74(4):205-214. PubMed ID: 29773262
    [Abstract] [Full Text] [Related]

  • 11. SMOKING CESSATION TREATMENTS: CURRENT PSYCHOLOGICAL AND PHARMACOLOGICAL OPTIONS.
    García-Gómez L, Hernández-Pérez A, Noé-Díaz V, Riesco-Miranda JA, Jiménez-Ruiz C.
    Rev Invest Clin; 2019 Sep 01; 71(1):7-16. PubMed ID: 30810545
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The safety of treatments for tobacco use disorder.
    Little MA, Ebbert JO.
    Expert Opin Drug Saf; 2016 Sep 01; 15(3):333-41. PubMed ID: 26715118
    [Abstract] [Full Text] [Related]

  • 14. Impact of Smoking and Smoking Cessation Medications in Aviators.
    Dailey JI, Wilson KC.
    Curr Psychiatry Rep; 2019 Nov 20; 21(12):127. PubMed ID: 31748911
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Increasing Smoking Cessation in the United States: Expanding the Availability of Over-the-Counter Medications.
    Leischow SJ.
    JAMA; 2019 Feb 12; 321(6):541-542. PubMed ID: 30653222
    [No Abstract] [Full Text] [Related]

  • 19. Modelling a budgetary impact analysis for funding drug-based smoking cessation therapies for patients with major depressive disorder in Spain.
    Rejas-Gutiérrez J, Bruguera E, Cedillo S.
    Eur Psychiatry; 2017 Sep 12; 45():41-49. PubMed ID: 28728094
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.